Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.35 EUR | -2.31% | +2.92% | +37.54% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
MarketScreener Editorial Features
Global markets live: Macy's, Salesforce, Dollar General, Nordstrom, Exxon... | June 01, 2023 at 11:48 am EDT | |
Alert: New entry in the European portfolio | August 30, 2021 at 05:57 am EDT |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- MarketScreener Editorial Features